Two cases of drug-induced immune hemolytic anemia.
نویسندگان
چکیده
منابع مشابه
Drug-induced immune hemolytic anemia.
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide the optimal serological tests to confirm the diagnosis. The most common drugs associated with DIIHA and the hypotheses for the mechanisms thought to be involved have changed during the last few decades. The drugs most frequently associated with DIIHA at this time are cefotetan, ceftri...
متن کاملTwo Cases of Chronic Hemolytic Anemia Associated with Spherocytosis
Two cases of hemolytic anemia with spherocytosis were investigated. lnspite of chronic hemolysis tl::crc was no radiological changes in flat bones. Management and entity of spherocytosis is discussed m detail in this paper.
متن کاملAlloantibodies and Drug-Induced Immune Hemolytic Anemia in Liver Transplantation
Red blood cell alloantibodies can cause severe delayed hemolysis, despite immunosuppression which they receive posttransplantation. A female patient with Hepatitis C-related chronic liver disease reported to our center for liver transplantation. During preoperative evaluation, she was found to have significant red blood cell alloantibodies which gave rise to problems during pre transfusion comp...
متن کاملImmune hemolytic anemia associated with drug therapy.
Drug-induced immune hemolytic anemia (DIIHA) is rare; it can be mild or associated with acute severe hemolytic anemia (HA) and death. About 125 drugs have been implicated as the cause. The HA can be caused by drug-independent antibodies that are indistinguishable, in vitro and in vivo, from autoantibodies causing idiopathic warm type autoimmune hemolytic anemia (AIHA). More commonly, the antibo...
متن کاملPathology consultation on drug-induced hemolytic anemia.
Drug-induced immune hemolytic anemia is considered to be rare but is likely underrecognized. The consulting pathologist plays a critical role in integrating serologic findings with the clinical history, as drug-induced antibodies should be distinguished as either drug-dependent or drug-independent for appropriate clinical management. Drug-dependent antibodies (DDABs) are most commonly associate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Japan Society of Blood Transfusion
سال: 1990
ISSN: 1883-8383,0546-1448
DOI: 10.3925/jjtc1958.36.614